David P Meeker Rhythm Pharmaceuticals, Inc. (RYTM) insider trading activity

David P Meeker is President and CEO of RHYTHM PHARMACEUTICALS, INC.. Currently has a direct ownership of 189,927 shares of RYTM, which is worth approximately $11.4 Million. The most recent transaction as insider was on Feb 04, 2025, when has been sold 4,278 shares (Common Stock) at a price of $59.43 per share, resulting in proceeds of $254,241. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 190K

8.78% 3M change

56.84% 12M change

Total Value Held $11.4 Million

David P Meeker Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 04 2025	SELL Open market or private sale	$254,241 $59.43 p/Share	4,278 Reduced 2.2%	189,927 Common Stock
Feb 01 2025	BUY Exercise of conversion of derivative security	-	14,125 Added 6.78%	194,205 Common Stock
Mar 19 2024	SELL Open market or private sale	$1,784,274 $39.22 p/Share	45,494 Reduced 20.67%	174,605 Common Stock
Feb 16 2024	BUY Grant, award, or other acquisition	-	99,000 Added 31.02%	220,099 Common Stock
Feb 01 2024	SELL Open market or private sale	$196,506 $45.06 p/Share	4,361 Reduced 3.48%	121,099 Common Stock
Feb 01 2024	BUY Exercise of conversion of derivative security	-	14,125 Added 10.12%	125,460 Common Stock
Mar 30 2021	BUY Open market or private purchase	$201,700 $20.17 p/Share	10,000 Added 8.24%	111,335 Common Stock

Also insider at

TRVI

Trevi Therapeutics, Inc. Healthcare

MYOK

MyoKardia Inc

Director

DPM

David P Meeker

President and CEO

Brisbane, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RYTM shares.

Notify only if

Value

Insider Trading

Get notified when an Rhythm Pharmaceuticals, Inc. insider buys or sells RYTM shares.

Notify only if

Operation

Value

Type

News

Receive news related to RHYTHM PHARMACEUTICALS, INC.

Track Activities on RYTM

Account